CHARACTERIZATION OF THE LUNG PGDH
肺 PGDH 的特征
基本信息
- 批准号:3320863
- 负责人:
- 金额:$ 10.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-09-01 至 1992-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The NAD+-dependent prostaglandin dehydrogenase (PGDH)
catalyzes the oxidation of the 15-hydroxyl group of prostaglandins
of the E and F series. This reaction represents the major route of
inactivation for these reactive compounds. 15-Hydroxy
compounds that did not posses the cyclopentane ring of
prostaglandins also were metabolized by this enzyme. 15-
Hydroxy-eicosatetraenoic acid (15-HETE) was observed to be a
substrate of the lung PGDH. The PGDH has been purified from
the lung of pregnant rabbits and will be used to study the
metabolism of 15-HETE and other 15-hydroxy-di- and triHETEs.
15-HETE may have important biological roles in modulating 5-and
12- lipoxygenase activities of white cells and mucus secretion in
the lung, thus the metabolism of 15-HETE may be important in
regulating its activity. The metabolism of other omega 6hydroxy-
fatty acids that contain 17- and 18-carbon atoms also will be
studied. Isolated lung perfusion studies will be performed to
determine if the metabolism of 15-HETE may occur in the whole
lung. The enzymatic activity of the lung PGDH is induced 20- to
40-fold during pregnancy of the rabbits but our studies indicate
that the amount of immunoreactive protein does not increase. An
inhibitory factor of the lung PGDH was isolated from the lungs of
pregnant rabbits. The inhibitor migrated with the neutral lipid
fraction and the evidence suggests it consists of free fatty acids.
This factor will be examined further to determine its identity and
to determine if the increase in PGDH activity during pregnancy is
due to changes in this inhibitor. The presence of this inhibitor is
important in understanding the expression and regulation of the
PGDH activity. An antibody to the PGDH has been made and will
be used to localize the enzyme by immunocytochemical
procedures at the light and electron microscope levels in the lung
and other rabbit tissues. The anti-lung PGDH also will be used to
characterize and compare the immunochemical properties of
PGDH enzymes from various tissues. PGDH activity is inhibited
by substances in cigarette smoke and this loss of enzymatic
activity may contribute to the vascular and airway changes
observed in cigarette smokers. The effects of acrolein, a reactive
aldehyde in cigarette smoke, will be studied on PGDH activity.
The studies described in this proposal will lead to a greater
characterization of this enzyme and the function of
prostaglandins and other eicosanoid derivatives in pulmonary
function, in pregnancy, and in pulmonary and cardiovascular
diseases.
NAD+ 依赖性前列腺素脱氢酶 (PGDH)
催化前列腺素 15-羟基的氧化
E 和 F 系列。 该反应代表了主要路线
这些活性化合物的失活。 15-羟基
不具有环戊烷环的化合物
前列腺素也通过这种酶代谢。 15-
据观察,羟基二十碳四烯酸 (15-HETE)
肺PGDH的底物。 PGDH 已纯化自
怀孕兔子的肺,将用于研究
15-HETE 和其他 15-羟基-二-和三HETE 的代谢。
15-HETE 可能在调节 5-和
12-白细胞的脂氧合酶活性和粘液分泌
肺,因此 15-HETE 的代谢可能很重要
调节其活动。 其他 omega 6 羟基的代谢
含有 17 和 18 个碳原子的脂肪酸也将
研究过。 将进行离体肺灌注研究
确定15-HETE的代谢是否可能发生在整个
肺。 肺PGDH的酶活性被诱导20-至
兔子怀孕期间增加了 40 倍,但我们的研究表明
免疫反应蛋白的量没有增加。 一个
肺抑制因子 PGDH 是从肺中分离出来的
怀孕的兔子。 抑制剂随中性脂质迁移
部分,证据表明它由游离脂肪酸组成。
将进一步检查该因素以确定其身份和
确定怀孕期间 PGDH 活性的增加是否与
由于该抑制剂的变化。 这种抑制剂的存在是
对于理解表达和调节很重要
PGDH 活性。 PGDH 抗体已制成,并将
用于通过免疫细胞化学定位酶
肺部光学和电子显微镜水平的手术
和其他兔组织。 抗肺PGDH也将用于
表征并比较免疫化学特性
来自各种组织的 PGDH 酶。 PGDH活性被抑制
香烟烟雾中的物质和酶的损失
活动可能会导致血管和气道的变化
在吸烟者中观察到。 反应活性物质丙烯醛的作用
香烟烟雾中的醛,将研究PGDH活性。
本提案中描述的研究将带来更大的成果
该酶的特性及其功能
肺中的前列腺素和其他类二十烷酸衍生物
功能、妊娠、肺和心血管
疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard T. Okita其他文献
Richard T. Okita的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard T. Okita', 18)}}的其他基金
DEHP-INDUCIBLE CYTOCHROME P450 FORMS IN KIDNEY AND LIVER
DEHP 诱导的细胞色素 P450 在肾脏和肝脏中的形式
- 批准号:
2153429 - 财政年份:1993
- 资助金额:
$ 10.3万 - 项目类别:
DEHP-INDUCIBLE CYTOCHROME P450 FORMS IN KIDNEY AND LIVER
DEHP 诱导的细胞色素 P450 在肾脏和肝脏中的形式
- 批准号:
2153428 - 财政年份:1993
- 资助金额:
$ 10.3万 - 项目类别:
DEHP-INDUCIBLE CYTOCHROME P450 FORMS IN KIDNEY AND LIVER
DEHP 诱导的细胞色素 P450 在肾脏和肝脏中的形式
- 批准号:
2414948 - 财政年份:1993
- 资助金额:
$ 10.3万 - 项目类别:
DEHP-INDUCIBLE CYTOCHROME P450 FORMS IN KIDNEY AND LIVER
DEHP 诱导的细胞色素 P450 在肾脏和肝脏中的形式
- 批准号:
2153430 - 财政年份:1993
- 资助金额:
$ 10.3万 - 项目类别:
相似海外基金
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 10.3万 - 项目类别:
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
- 批准号:
EP/Y024540/1 - 财政年份:2024
- 资助金额:
$ 10.3万 - 项目类别:
Fellowship
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
- 批准号:
MR/Y008847/1 - 财政年份:2024
- 资助金额:
$ 10.3万 - 项目类别:
Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
- 批准号:
BB/Y002180/1 - 财政年份:2024
- 资助金额:
$ 10.3万 - 项目类别:
Research Grant
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 10.3万 - 项目类别:
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 10.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
- 批准号:
MR/Y003616/1 - 财政年份:2024
- 资助金额:
$ 10.3万 - 项目类别:
Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
- 批准号:
MR/Y033698/1 - 财政年份:2024
- 资助金额:
$ 10.3万 - 项目类别:
Research Grant
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
- 批准号:
23H03716 - 财政年份:2023
- 资助金额:
$ 10.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis research of anti-Sez6l2 antibody associated encephalopathy
抗Sez6l2抗体相关脑病的分析研究
- 批准号:
23K06940 - 财政年份:2023
- 资助金额:
$ 10.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)